Internationally renowned OHSU cancer biologist elected to the National Academy of Sciences
Lisa Coussens, Ph.D., earns one of the highest honors in the field of science and research.
Related Articles
AACR 2024 Annual Meeting Guide
Carry the AACR Annual Meetin g 2024 with you wherever you go. All app content and functions (including abstracts) can be accessed without an Internet…
Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy
Chimeric antigen receptor T cell (CAR-T) therapy targeting GD2 in osteosarcoma and neuroblastoma in a Phase I clinical trial shows feasibility and safety but limited efficacy.…
Don’t get mad, get equal: putting an end to misogyny in science
Subtle forms of misogyny attack female leadership and coerce women to conform to conventional gender norms. It’s time to call out these behaviours, say Alison…
OHSU research offers clues for potential widespread HIV cure in people
New study reveals first details on how stem cell transplantation can kill virus that causes AIDS.
A Black 11-year-old called 911. Police arrived and shot him, his mom says. — The Washington Post
The family of Aderrien Murry and the community in Indianola, Miss., are calling for the officer who shot the 11-year-old to be fired.
What Rosalind Franklin truly contributed to the discovery of DNA’s structure
Franklin was no victim in how the DNA double helix was solved. An overlooked letter and an unpublished news article, both written in 1953, reveal…
Social and Economic Policies Can Help Reverse Americans’ Declining Health
To meaningfully improve the health of Americans, new policies must target all of the drivers of health, including education, economic stability, neighborhoods and environments, social…
‘How Will I Pump?’: When Your First Work Trip After Maternity Leave Is to Ukraine With President Biden — The Wall Street Journal
A working mom opens her reporter’s notebook from a historic trip to a war zone that carries special meaning, and logistics
OHSU researchers identify promising next-generation cancer treatment
Chemistry discovery points to next generation inhibitors of PARP-1, a critical target in ovarian, breast and prostate cancers.
Fred Hutch launches MET-X, a ‘transformative approach to metastatic disease’
Fred Hutch translational researcher Dr. Cyrus Ghajar will lead a new Center for Metastasis Research Excellence, or MET-X, which will focus specifically on preventing, treating…